SQUASSINA, ALESSIO
 Distribuzione geografica
Continente #
EU - Europa 224.729
NA - Nord America 12.961
AS - Asia 6.367
SA - Sud America 1.282
AF - Africa 211
OC - Oceania 28
Continente sconosciuto - Info sul continente non disponibili 3
Totale 245.581
Nazione #
IT - Italia 221.452
US - Stati Uniti d'America 12.660
SG - Singapore 2.400
CN - Cina 1.958
BR - Brasile 975
VN - Vietnam 699
SE - Svezia 679
UA - Ucraina 520
DE - Germania 448
GB - Regno Unito 405
FI - Finlandia 353
FR - Francia 286
HK - Hong Kong 286
BD - Bangladesh 177
IN - India 175
CA - Canada 173
NL - Olanda 144
AR - Argentina 114
KR - Corea 113
MX - Messico 75
IQ - Iraq 68
JP - Giappone 67
TR - Turchia 65
AT - Austria 57
ES - Italia 56
ZA - Sudafrica 56
MA - Marocco 52
RU - Federazione Russa 52
PL - Polonia 51
EC - Ecuador 47
ID - Indonesia 40
BE - Belgio 38
CO - Colombia 37
SA - Arabia Saudita 33
VE - Venezuela 33
IE - Irlanda 31
PK - Pakistan 31
UZ - Uzbekistan 30
AU - Australia 27
PH - Filippine 26
CL - Cile 24
MY - Malesia 21
NO - Norvegia 21
CZ - Repubblica Ceca 20
IR - Iran 18
JO - Giordania 18
EG - Egitto 17
LT - Lituania 17
PY - Paraguay 17
AE - Emirati Arabi Uniti 16
AZ - Azerbaigian 13
DK - Danimarca 13
IL - Israele 13
TN - Tunisia 13
CH - Svizzera 12
DZ - Algeria 12
KE - Kenya 12
KZ - Kazakistan 12
PE - Perù 12
PT - Portogallo 12
BO - Bolivia 10
GR - Grecia 10
JM - Giamaica 10
NP - Nepal 10
PS - Palestinian Territory 10
UY - Uruguay 10
ET - Etiopia 8
QA - Qatar 8
CI - Costa d'Avorio 7
KG - Kirghizistan 7
LB - Libano 7
RS - Serbia 7
SN - Senegal 7
TH - Thailandia 7
DO - Repubblica Dominicana 6
GT - Guatemala 6
HR - Croazia 6
NG - Nigeria 6
OM - Oman 6
RO - Romania 6
CR - Costa Rica 5
GE - Georgia 5
MD - Moldavia 5
NI - Nicaragua 5
AM - Armenia 4
BG - Bulgaria 4
BY - Bielorussia 4
PA - Panama 4
PR - Porto Rico 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
AL - Albania 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
IS - Islanda 3
KW - Kuwait 3
LV - Lettonia 3
CY - Cipro 2
Totale 245.530
Città #
Cagliari 215.022
Uta 5.408
Ashburn 1.237
Singapore 1.228
Fairfield 1.063
Dallas 921
San Jose 883
Woodbridge 765
Chandler 647
Houston 541
Boardman 486
Seattle 426
Wilmington 387
Beijing 377
Nyköping 348
Ann Arbor 341
Cambridge 338
New York 319
Los Angeles 286
Hong Kong 250
Jacksonville 247
Ho Chi Minh City 219
Council Bluffs 217
Helsinki 213
The Dalles 212
Santa Clara 190
Dearborn 175
Hefei 165
Lauterbourg 159
Shanghai 157
Hanoi 137
Boston 135
Rome 113
Nanjing 100
Seoul 99
Buffalo 93
São Paulo 92
Dong Ket 89
Frankfurt am Main 72
Orem 69
Chicago 68
San Diego 62
Munich 61
Atlanta 60
Cardiff 58
Tokyo 58
Milan 54
Nieuwegein 54
Montreal 52
London 50
Redondo Beach 50
Redwood City 49
Norwalk 47
Nuremberg 47
Guangzhou 46
Johannesburg 43
Chennai 42
Toronto 41
Lappeenranta 40
Warsaw 40
Brooklyn 39
Brussels 36
Amsterdam 35
Rio de Janeiro 35
Shenyang 35
Tianjin 35
Denver 34
Casablanca 33
Hebei 33
Poplar 33
Da Nang 32
Nanchang 32
Stockholm 32
Changsha 31
Phoenix 31
Jiaxing 30
Haiphong 27
San Francisco 27
Mexico City 26
Vienna 26
Tashkent 24
Turku 24
Dublin 23
Verona 23
Hangzhou 22
Naples 22
Zhengzhou 22
Baghdad 21
Mountain View 21
Pune 20
Manchester 19
Oslo 19
Columbus 18
Guayaquil 18
Sassari 18
Shenzhen 18
Washington 18
Berlin 17
Brasília 17
City of London 17
Totale 236.291
Nome #
Leukocyte telomere length positively correlates with duration of lithium treatment in bipolar disorder patients 4.373
Count of “dark telomere” on the track of a biomarker for lithium treatment in bipolar disorder 4.266
Major depression subtypes are differentially associated with migraine subtype, prevalence and severity 3.627
Whole Genome Expression Analyses of miRNAs and mRNAs Suggest the Involvement of miR-320a and miR-155-3p and their Targeted Genes in Lithium Response in Bipolar Disorder 3.572
Pharmacogenetics of lithium effects on glomerular function in bipolar disorder patients under chronic lithium treatment: a pilot study 3.512
A multidisciplinary approach to mental illness: Do inflammation, telomere length and microbiota form a loop? A protocol for a cross-sectional study on the complex relationship between inflammation, telomere length, gut microbiota and psychiatric disorders 3.512
Challenges and Future Prospects of Precision Medicine in Psychiatry 3.425
Differences in telomere length between patients with bipolar disorder and controls are influenced by lithium treatment 3.146
Analysis of the influence of microRNAs in lithium response in bipolar disorder 3.066
Preliminary transcriptome analysis in lymphoblasts from cluster headache and bipolar disorder patients implicates dysregulation of circadian and serotonergic genes 3.051
Evidence towards RNA Binding Motif (RNP1, RRM) Protein 3 (RBM3) as a Potential Biomarker of Lithium Response in Bipolar Disorder Patients 3.051
Exploring the role of gut microbiota in major depressive disorder and in treatment resistance to antidepressants 3.018
Convergent analysis of genome-wide genotyping and transcriptomic data suggests association of zinc finger genes with lithium response in bipolar disorder 3.011
Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study 2.926
Association of polygenic score for major depression with response to lithium in patients with bipolar disorder 2.923
Exposure and duration of lithium treatment affect leukocyte telomere length in bipolar disorder patients 2.896
Telomere attrition and inflammatory load in severe psychiatric disorders and in response to psychotropic medications 2.889
Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study 2.885
HDAC3 role in medication consumption in medication overuse headache patients: a pilot study 2.825
Involvement of core clock genes in lithium response 2.818
Differential effect of lithium on spermidine/spermine N1-acetiltransferase expression in suicidal behaviour 2.746
Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder. A genome-wide association study 2.715
Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients 2.679
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.677
Investigating the relationship between melatonin levels, melatonin system, microbiota composition and bipolar disorder psychopathology across the different phases of the disease 2.676
Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder 2.673
Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: potential involvement of epigenetics 2.670
Increasing engagement in pharmacology and pharmacogenetics education using games and online resources: the PharmacoloGenius mobile app 2.649
null 2.498
Pharmacogenomics of mood stabilizers in the treatment of bipolar disorder 2.459
Novel integrative genomic tool for interrogating lithium response in bipolar disorder 2.412
Pharmacogenomics of bipolar disorder 2.404
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample 2.381
The impact of depot and long acting injectable antipsychotics on serum levels of brain-derived neurotrophic factor in schizophrenic and schizoaffective patients: results of a 24-month longitudinal prospective study 2.355
Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing 2.302
Lithium pharmacogenetics: Where do we stand? 2.287
Mood Disorders, Accelerated Aging, and Inflammation: Is the Link Hidden in Telomeres? 2.231
Exemplar scoring identifies genetically separable phenotypes of lithium responsive bipolar disorder 2.192
Cellular models to study bipolar disorder: a systematic review 2.179
Age at onset in bipolar disorder: investigation of the role of TaqIA polymorphism of DRD2 gene in a Sardinian sample 2.151
Lithium-induced differential expression of SAT1 in suicide completers and controls is not correlated with polymorphisms in the promoter region of the gene 2.106
557. Pharmacogenetic Association of Lithium Treatment Response with Bcl2 Polymorphism in Bipolar Disorder 2.088
Characterisation of age and polarity at onset in bipolar disorder 2.027
An examination of the quality and performance of the Alda scale for classifying lithium response phenotypes 2.008
Assessment of response to lithium maintenance treatment in bipolar disorder: A Consortium on Lithium Genetics (ConLiGen) report 1.982
null 1.980
Variant GADL1 and response to lithium in bipolar I disorder 1.978
MicroRNA expression profiling of lymphoblasts from bipolar disorder patients who died by suicide, pathway analysis and integration with postmortem brain findings 1.940
Clinical, genetic, and brain imaging predictors of risk for bipolar disorder in high-risk individuals 1.890
Lithium pharmacogenetics 1.860
A genetic risk score is differentially associated with migraine with and without aura 1.853
Positive Association Between REV-ERB Alpha Gene and Bipolar Disorder in a Sardinian Population 1.848
null 1.842
Candidate Genes in Bipolar 1 Sradinian Patients : A case control Study 1.824
The international consortium on lithium genetics (ConLiGen): An initiative by the NIMH and IGSLI to study the genetic basis of response to lithium treatment 1.791
Doctors and researchers: integrating data for bipolar disorder studies 1.767
Evidence that genes involved in hedgehog signaling are associated with both bipolar disorder and high BMI 1.728
Zinc finger proteins in psychiatric disorders and response to psychotropic medications 1.674
A European spectrum of pharmacogenomic biomarkers: Implications for clinical pharmacogenomics 1.670
Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine. 1.668
Leukocyte telomere length is reduced in patients with major depressive disorder 1.664
Prediction of lithium response using genomic data 1.655
Presenting Psychiatric and Neurological Symptoms and Signs of Brain Tumors before Diagnosis: A Systematic Review 1.633
Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches 1.609
Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients 1.603
null 1.525
We are not alone in our body: insights into the involvement of microbiota in the etiopathogenesis and pharmacology of mental illness 1.519
Recent trends on the role of epigenomics, metabolomics and noncoding RNAs in rationalizing mood stabilizing treatment 1.505
null 1.449
null 1.424
null 1.414
A case-control association study of the PDLIM5 gene and bipolar disorder in a Sardinian sample 1.388
RGS2 expression predicts amyloid-β sensitivity, MCI and Alzheimer's disease: genome-wide transcriptomic profiling and bioinformatics data mining 1.327
Telomere length in bipolar disorder and lithium response 1.308
Protocol for a pharmacogenetic study of antidepressants: characterization of drug-metabolizing profiles of cytochromes CYP2D6 and CYP2C19 in a Sardinian population of patients with major depressive disorder 1.272
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia 1.270
RNA sequencing of bipolar disorder lymphoblastoid cell lines implicates the neurotrophic factor HRP-3 in lithium clinical efficacy 1.257
Exploring the association between brain-derived neurotrophic factor levels and longitudinal psychopathological and cognitive changes in Sardinian psychotic patients 1.254
Interacting genes in lithium prophylaxis: preliminary results of an exploratory analysis on the role of DGKH and NR1D1 gene polymorphisms in 199 Sardinian bipolar patiens 1.242
Investigation of genetic loci shared between bipolar disorder and risk-taking propensity: potential implications for pharmacological interventions 1.232
Genetic, demographic and archival study on a Sardinian village (Escalaplano) Italy 1.228
Association of Attention-Deficit/Hyperactivity Disorder and Depression Polygenic Scores with Lithium Response: A Consortium for Lithium Genetics Study 1.203
Haplotype association study between DRD1 gene and parasuicide in bipolar disorder: Analysis of two samples from Canada and Sardinia 1.195
The Role of Pharmacogenomics in Bipolar Disorder: Moving Towards Precision Medicine 1.189
Assessment of the pharmacogenomics educational environment in southeast europe 1.183
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease 1.169
null 1.161
null 1.156
null 1.146
Alzheimer’s disease: case-control study of polymorphisms in ACHE, CHAT and BCHE genes in a Sardininan sample 1.120
Investigation of the genetic interaction between BDNF and DRD3 genes in suicidical behaviour in psychiatric disorders 1.117
Candidate Genes in Bipolar 1 Sardinian Patients : A case control Study 1.061
The diacylglycerol kinase eta gene and bipolar disorder: a replication study in a Sardinian sample 1.055
Genetically elevated high-density lipoprotein cholesterol through cholesteryl ester transfer protein does not associate with risk of Alzheimer's disease 1.021
HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders 1.018
An introduction to pharmacogenomics and personalized medicine 1.017
Association study in a Sardinian sample between Bipolar Disorder and the nuclear receptor REV-ERBalpha gene, a critical component of the circadian clock system 1.015
A genome-wide association study of antidepressant-induced mania 991
2016 Golden Helix Summer School - Cancer Genomics and Individualized Therapy. 22-26 September 2016, Syros Island, Greece: Abstracts 980
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy 973
Totale 202.200
Categoria #
all - tutte 316.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 316.054


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.162 0 0 0 0 0 0 0 0 0 0 0 2.162
2021/202214.228 1.839 965 810 1.128 1.149 840 868 680 1.363 1.464 1.732 1.390
2022/202320.269 1.298 2.583 2.690 1.780 1.547 2.277 977 1.292 1.482 1.494 1.874 975
2023/202420.567 915 746 795 1.387 1.949 3.193 3.207 1.447 981 1.349 2.332 2.266
2024/202553.948 16.213 17.375 4.848 4.853 2.500 2.695 3.298 211 496 443 395 621
2025/202615.390 1.126 722 1.825 1.636 1.249 1.195 2.273 1.323 957 1.766 890 428
Totale 246.374